Annual Net Income
-$22.94 M
-$1.95 M-9.26%
December 31, 2023
Summary
- As of March 13, 2025, MTNB annual net profit is -$22.94 million, with the most recent change of -$1.95 million (-9.26%) on December 31, 2023.
- During the last 3 years, MTNB annual net income has fallen by -$495.20 thousand (-2.21%).
- MTNB annual net income is now -517.87% below its all-time high of -$3.71 million, reached on December 31, 2013.
Performance
MTNB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$4.28 M
+$1.44 M+25.25%
September 30, 2024
Summary
- As of March 13, 2025, MTNB quarterly net profit is -$4.28 million, with the most recent change of +$1.44 million (+25.25%) on September 30, 2024.
- Over the past year, MTNB quarterly net income has increased by +$1.78 million (+29.40%).
- MTNB quarterly net income is now -3713.56% below its all-time high of -$112.10 thousand, reached on March 31, 2013.
Performance
MTNB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$21.13 M
+$1.78 M+7.77%
September 30, 2024
Summary
- As of March 13, 2025, MTNB TTM net profit is -$21.13 million, with the most recent change of +$1.78 million (+7.77%) on September 30, 2024.
- Over the past year, MTNB TTM net income has increased by +$130.00 thousand (+0.61%).
- MTNB TTM net income is now -18751.03% below its all-time high of -$112.10 thousand, reached on March 31, 2013.
Performance
MTNB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MTNB Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.3% | +29.4% | +0.6% |
| 3 y3 years | -2.2% | +29.4% | +0.6% |
| 5 y5 years | -62.9% | +29.4% | +0.6% |
MTNB Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.3% | +1.5% | -17.6% | +36.2% | -2.9% | +16.9% |
| 5 y | 5-year | -32.1% | +1.5% | -17.6% | +37.5% | -21.6% | +16.9% |
| alltime | all time | -517.9% | +1.5% | -3713.6% | +37.5% | <-9999.0% | +16.9% |
Matinas BioPharma Holdings Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.28 M(-25.2%) | -$21.13 M(-7.8%) |
| Jun 2024 | - | -$5.72 M(-1.8%) | -$22.91 M(-1.5%) |
| Mar 2024 | - | -$5.82 M(+9.6%) | -$23.25 M(+1.4%) |
| Dec 2023 | -$22.94 M(+9.3%) | -$5.31 M(-12.2%) | -$22.94 M(+7.9%) |
| Sep 2023 | - | -$6.05 M(-0.1%) | -$21.26 M(+2.9%) |
| Jun 2023 | - | -$6.06 M(+9.9%) | -$20.67 M(+0.7%) |
| Mar 2023 | - | -$5.51 M(+51.7%) | -$20.53 M(-2.2%) |
| Dec 2022 | -$21.00 M(-9.8%) | -$3.63 M(-33.5%) | -$21.00 M(-12.7%) |
| Sep 2022 | - | -$5.46 M(-7.8%) | -$24.06 M(-5.4%) |
| Jun 2022 | - | -$5.92 M(-0.9%) | -$25.44 M(+4.7%) |
| Mar 2022 | - | -$5.98 M(-10.8%) | -$24.30 M(+4.4%) |
| Dec 2021 | -$23.28 M(+3.7%) | -$6.70 M(-2.0%) | -$23.28 M(+1.6%) |
| Sep 2021 | - | -$6.84 M(+42.7%) | -$22.92 M(+6.4%) |
| Jun 2021 | - | -$4.79 M(-3.3%) | -$21.54 M(-3.7%) |
| Mar 2021 | - | -$4.96 M(-21.8%) | -$22.36 M(-0.4%) |
| Dec 2020 | -$22.45 M(+29.2%) | -$6.34 M(+16.4%) | -$22.45 M(+3.5%) |
| Sep 2020 | - | -$5.45 M(-2.9%) | -$21.68 M(+5.1%) |
| Jun 2020 | - | -$5.61 M(+11.2%) | -$20.63 M(+12.3%) |
| Mar 2020 | - | -$5.05 M(-9.5%) | -$18.37 M(+5.7%) |
| Dec 2019 | -$17.37 M(+23.4%) | -$5.57 M(+26.5%) | -$17.37 M(+12.6%) |
| Sep 2019 | - | -$4.40 M(+31.7%) | -$15.43 M(+10.5%) |
| Jun 2019 | - | -$3.34 M(-17.4%) | -$13.96 M(-0.5%) |
| Mar 2019 | - | -$4.05 M(+11.7%) | -$14.02 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$14.08 M(-9.1%) | -$3.63 M(+23.5%) | -$14.08 M(-0.0%) |
| Sep 2018 | - | -$2.94 M(-13.9%) | -$14.08 M(-3.2%) |
| Jun 2018 | - | -$3.41 M(-17.0%) | -$14.54 M(-3.7%) |
| Mar 2018 | - | -$4.11 M(+13.3%) | -$15.10 M(-2.5%) |
| Dec 2017 | -$15.49 M(+103.8%) | -$3.63 M(+6.9%) | -$15.49 M(+12.6%) |
| Sep 2017 | - | -$3.39 M(-14.4%) | -$13.75 M(+12.8%) |
| Jun 2017 | - | -$3.97 M(-11.8%) | -$12.19 M(+23.8%) |
| Mar 2017 | - | -$4.50 M(+137.7%) | -$9.85 M(+29.6%) |
| Dec 2016 | -$7.60 M(-16.8%) | -$1.89 M(+2.9%) | -$7.60 M(-1.5%) |
| Sep 2016 | - | -$1.84 M(+13.2%) | -$7.71 M(-3.9%) |
| Jun 2016 | - | -$1.62 M(-27.7%) | -$8.03 M(-8.9%) |
| Mar 2016 | - | -$2.24 M(+11.9%) | -$8.81 M(-3.6%) |
| Dec 2015 | -$9.14 M(-10.6%) | -$2.01 M(-6.9%) | -$9.14 M(-10.2%) |
| Sep 2015 | - | -$2.15 M(-10.4%) | -$10.17 M(-4.3%) |
| Jun 2015 | - | -$2.40 M(-6.4%) | -$10.63 M(-0.2%) |
| Mar 2015 | - | -$2.57 M(-15.6%) | -$10.65 M(+4.2%) |
| Dec 2014 | -$10.22 M(+175.3%) | -$3.04 M(+16.6%) | -$10.22 M(+13.8%) |
| Sep 2014 | - | -$2.61 M(+7.7%) | -$8.98 M(+14.8%) |
| Jun 2014 | - | -$2.43 M(+13.4%) | -$7.82 M(+36.3%) |
| Mar 2014 | - | -$2.14 M(+18.7%) | -$5.74 M(+54.6%) |
| Dec 2013 | -$3.71 M | -$1.80 M(+23.7%) | -$3.71 M(+94.2%) |
| Sep 2013 | - | -$1.46 M(+324.2%) | -$1.91 M(+319.8%) |
| Jun 2013 | - | -$343.30 K(+206.2%) | -$455.40 K(+306.2%) |
| Mar 2013 | - | -$112.10 K | -$112.10 K |
FAQ
- What is Matinas BioPharma Holdings annual net profit?
- What is the all time high annual net income for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual net income year-on-year change?
- What is Matinas BioPharma Holdings quarterly net profit?
- What is the all time high quarterly net income for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly net income year-on-year change?
- What is Matinas BioPharma Holdings TTM net profit?
- What is the all time high TTM net income for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM net income year-on-year change?
What is Matinas BioPharma Holdings annual net profit?
The current annual net income of MTNB is -$22.94 M
What is the all time high annual net income for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual net profit is -$3.71 M
What is Matinas BioPharma Holdings annual net income year-on-year change?
Over the past year, MTNB annual net profit has changed by -$1.95 M (-9.26%)
What is Matinas BioPharma Holdings quarterly net profit?
The current quarterly net income of MTNB is -$4.28 M
What is the all time high quarterly net income for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly net profit is -$112.10 K
What is Matinas BioPharma Holdings quarterly net income year-on-year change?
Over the past year, MTNB quarterly net profit has changed by +$1.78 M (+29.40%)
What is Matinas BioPharma Holdings TTM net profit?
The current TTM net income of MTNB is -$21.13 M
What is the all time high TTM net income for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM net profit is -$112.10 K
What is Matinas BioPharma Holdings TTM net income year-on-year change?
Over the past year, MTNB TTM net profit has changed by +$130.00 K (+0.61%)